Articles From: TherapeuticsMD Announces $50,000,000 Proposed Public Offering of Common Stock to Thermo Fisher Scientific to Present at the Cowen and Company 33rd Annual Health Care Conference on March 5, 2013


2013/3/7
TherapeuticsMD, Inc. (OTCQB: TXMD) today announced that it intends to offer and sell, subject to market and other conditions, $50,000,000 of its common stock in an underwritten public offering.
Sign-up for TherapeuticsMD Announces $50,000,000 Proposed Public Offering of Common Stock investment picks
2013/3/15
TherapeuticsMD, Inc. (OTCQB: TXMD) today announced the pricing of its previously announced underwritten public offering of 29,411,765 shares of its common stock, offered at a price of $1.70 per share to the public.
Sign-up for TherapeuticsMD Announces Pricing of Public Offering of Common Stock investment picks
2013/3/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0862213001&sourceType=1 http://www.ccnmatthews.com/logos/20051128-ther1.jpg MONTREAL, CANADA --
Sign-up for Theratechnologies Inc.: Health Canada Decision Appealed investment picks
2013/3/4
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0857748001&sourceType=1 http://www.ccnmatthews.com/logos/20051128-ther1.jpg MONTREAL, CANADA --
Sign-up for Theratechnologies Inc.: Health Canada Issues Decision on Tesamorelin investment picks
2013/5/13
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://media.marketwire.com/attachments/201305/61075_elanlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1016530&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA and DUBLIN, IRELAND --
Sign-up for Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement investment picks
2013/4/25
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010911&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Announces Plan to Separate Late-Stage Partnered Respiratory Assets From Biopharmaceutical Operations investment picks
2013/4/25
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1010859&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance Reports First Quarter 2013 Financial Results investment picks
2013/2/21
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=988474&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at Investor Conferences in March 2013 investment picks
2013/4/23
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1009760&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at Investor Conferences in May 2013 investment picks
2013/2/13
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=985170&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the 2013 Citi Global Healthcare Conference investment picks
2013/1/31
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=980694&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Present at the Leerink Swann Global Healthcare Conference 2013 investment picks
2013/4/11
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1006375&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report First Quarter 2013 Financial Results on April 25, 2013 investment picks
2013/1/29
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979604&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Report Fourth Quarter and Full Year 2012 Financial Results on February 12, 2013 investment picks
2013/4/18
http://media.marketwire.com/attachments/201210/52482_theravance_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1008400&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Theravance to Webcast 2013 Annual Meeting of Stockholders on April 24, 2013 investment picks
2013/4/15
Amid a prolonged slump in the magazine business, there are some encouraging data for publishers.
Sign-up for There's a Digital Bright Spot for Some Magazine Publishers investment picks
2013/5/7
Where You Live with Asthma Matters, Air Quality is Just One of Many Factors WASHINGTON , May 7, 2013 /PRNewswire-USNewswire/ -- There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live.
Sign-up for There's More To Asthma Than Meets The Air investment picks
2013/3/22
Mentor Graphics Corporation (NASDAQ: MENT) today announced that Dr.
Sign-up for Thermal Measurement Expert Dr. Andras Poppe Honored with the Harvey Rosten Award For Excellence investment picks
2013/4/24
Thermo Fisher Scientific Inc.'s (TMO) first-quarter earnings rose 21% as a double-digit rise in specialty-diagnostics revenue contributed to stronger-than-expected revenue growth.
Sign-up for Thermo Fisher 1st-Quarter Net Rises 21% on Strong Specialty-Diagnostics Revenue investment picks
2013/4/15
With its $13.6 billion acquisition of Life Technologies Corp.
Sign-up for Thermo Fisher Enters Field of Gene Sequencing investment picks
2013/4/15
With its $13.6 billion acquisition of Life Technologies Corp.
Sign-up for Thermo Fisher Enters Uncertain Field of Gene Sequencing With Life Deal investment picks
2013/4/16
Moody's Investors Service and Fitch Ratings placed their credit ratings on Thermo Fisher Scientific Inc. (TMO) on review for a potential downgrade, after the company said it would acquire fellow laboratory-equipment maker Life Technologies Corp.
Sign-up for Thermo Fisher Ratings on Review investment picks
2013/3/18
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, today announced that it is launching significant innovations in software, instruments, consumables and services that unify its industry-leading analytical instrument platforms and enable customers to turn data into knowledge faster and more reliably.
Sign-up for Thermo Fisher Scientific Breaks New Ground to Drive Customer Innovation and Productivity investment picks
2013/2/27
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, today announced that its board of directors has declared a quarterly cash dividend of $0.15 per share.
Sign-up for Thermo Fisher Scientific Declares Quarterly Dividend investment picks
2013/4/24
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2013.
Sign-up for Thermo Fisher Scientific Reports First Quarter 2013 Results investment picks
2013/1/31
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2012.
Sign-up for Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2012 Results investment picks
2013/4/15
Thermo Fisher Scientific (NYSE: TMO) , the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE) , a leading life sciences company, have signed a definitive agreement under which Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share, or approximately $13.6 billion, plus the assumption of net debt at close ($2.2 billion as of year end 2012). The transaction, which was approved by both companies’ boards of directors, will create an unrivaled leader in serving research, specialty diagnostics and applied markets.
Sign-up for Thermo Fisher Scientific to Acquire Life Technologies Corporation investment picks
2013/4/3
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, announced that it will release its financial results for the first quarter 2013 before the market opens on Wednesday, April 24, 2013, and will hold a conference call on the same day at 8:30 a.m. EDT.
Sign-up for Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2013 investment picks
2013/5/8
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, announced that it will host its 2013 Analyst Meeting on Wednesday, May 22, from 9:00 a.m. to noon (EDT), at the New York Hilton Midtown, 1335 Avenue of Americas, New York City.
Sign-up for Thermo Fisher Scientific to Host Analyst Meeting investment picks
2013/5/7
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, announced that Marc N.
Sign-up for Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 14, 2013 investment picks
2013/2/26
Thermo Fisher Scientific Inc. (NYSE: TMO) , the world leader in serving science, announced that Marc N.
Sign-up for Thermo Fisher Scientific to Present at the Cowen and Company 33rd Annual Health Care Conference on March 5, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: TherapeuticsMD Announces $50,000,000 Proposed Public Offering of Common Stock to Thermo Fisher Scientific to Present at the Cowen and Company 33rd Annual Health Care Conference on March 5, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity